Stay updated on Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.

Latest updates to the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page
- Check4 days agoChange DetectedPage revision updated to v3.6.3, replacing the previous v3.6.2, indicating a new version of the ClinicalTrials.gov page.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page now shows revision v3.6.2 instead of v3.6.0 in the footer, indicating a small maintenance update.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedNew navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the revision tag updated to v3.6.0, with the older v3.5.5 removed. A recruitment status note No longer looking for participants appears, signaling termination due to low accrual.SummaryDifference0.5%

- Check33 days agoChange DetectedThe page revision tag was updated to v3.5.5, indicating a newer version of the page or site software. This change appears to be a maintenance update and does not modify the study details or other user-facing content.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, indicating a new page version. This change does not modify the study details or other content on the page.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page’s displayed “Revision” version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Plus Ibrutinib in Waldenstrӧm's Clinical Trial page.